The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Simpson Curran since 2009.
This trader's CIK number is 1346164.
At the time of last reporting, Simpson Curran was the Chief Executive Officer of Regenxbio Inc.. (stock ticker symbol RGNX).
Also see all insider trading activities at Regenxbio Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | RGNX | 0 | $0 | 9,748 | $146,605 | 0 | $0 |
| 2021 | RGNX | 0 | $0 | 18,497 | $925,068 | 18,497 | $455,328 |
| 2020 | RGNX | 0 | $0 | 68,552 | $3,446,797 | 48,552 | $1,209,772 |
| 2019 | RGNX | 0 | $0 | 82,684 | $4,063,215 | 67,132 | $1,576,254 |
| 2018 | RGNX | 0 | $0 | 120,191 | $6,696,683 | 120,191 | $2,407,240 |
| 2017 | RGNX | 0 | $0 | 54,000 | $1,710,395 | 54,000 | $1,071,679 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | HGSI | 0 | $0 | 50,919 | $1,432,964 | 50,919 | $598,080 |
| 2010 | HGSI | 0 | $0 | 124,825 | $3,738,088 | 124,825 | $1,356,607 |
| 2009 | HGSI | 0 | $0 | 125,878 | $2,307,456 | 118,457 | $928,990 |
2. Human Genome Sciences Inc (HGSI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-01 | RGNX | Sale | 100 | 15.00 | 1,500 |
| 2024-07-29 | RGNX | Sale | 9,648 | 15.04 | 145,105 |
| 2021-01-12 | RGNX | Option Ex | 1,700 | 19.50 | 33,150 |
| 2021-01-12 | RGNX | Sale | 1,700 | 50.03 | 85,051 |
| 2021-01-14 | RGNX | Option Ex | 11,612 | 27.65 | 321,071 |
| 2021-01-14 | RGNX | Sale | 11,612 | 50.01 | 580,716 |
| 2021-01-07 | RGNX | Option Ex | 5,185 | 19.50 | 101,107 |
| 2021-01-07 | RGNX | Sale | 5,185 | 50.01 | 259,301 |
| 2020-02-11 | RGNX | Sale | 12,564 | 50.75 | 637,623 |
| 2020-02-10 | RGNX | Option Ex | 31,660 | 25.77 | 815,783 |
| 2020-02-11 | RGNX | Option Ex | 6,633 | 22.00 | 145,926 |
| 2020-02-10 | RGNX | Sale | 44,429 | 50.22 | 2,231,224 |
| 2020-02-05 | RGNX | Option Ex | 5,137 | 22.60 | 116,085 |
| 2020-02-05 | RGNX | Sale | 5,637 | 50.00 | 281,850 |
| 2020-01-17 | RGNX | Sale | 5,922 | 50.00 | 296,100 |
| 2020-01-17 | RGNX | Option Ex | 5,122 | 25.77 | 131,978 |
| 2019-12-09 | RGNX | Sale | 15,552 | 43.83 | 681,644 |
| 2019-05-28 | RGNX | Option Ex | 18,000 | 22.00 | 396,000 |
| 2019-05-28 | RGNX | Sale | 18,000 | 50.00 | 900,000 |
| 2019-02-25 | RGNX | Sale | 5,300 | 54.05 | 286,465 |
| 2019-02-25 | RGNX | Option Ex | 5,300 | 35.80 | 189,739 |
| 2019-02-05 | RGNX | Option Ex | 43,832 | 22.60 | 990,515 |
| 2019-02-05 | RGNX | Sale | 43,832 | 50.08 | 2,195,106 |
| 2018-11-16 | RGNX | Option Ex | 32,882 | 22.00 | 723,404 |
| 2018-11-16 | RGNX | Sale | 32,882 | 63.26 | 2,080,181 |
| 2018-10-16 | RGNX | Option Ex | 62,309 | 18.20 | 1,133,836 |
| 2018-10-16 | RGNX | Sale | 62,309 | 60.85 | 3,791,502 |
| 2018-03-13 | RGNX | Option Ex | 25,000 | 22.00 | 550,000 |
| 2018-03-13 | RGNX | Sale | 25,000 | 33.00 | 825,000 |
| 2017-12-22 | RGNX | Option Ex | 30,000 | 22.00 | 660,000 |
| 2017-12-22 | RGNX | Sale | 30,000 | 33.03 | 990,900 |
| 2017-12-07 | RGNX | Option Ex | 21,890 | 17.55 | 384,060 |
| 2017-12-07 | RGNX | Sale | 21,890 | 30.04 | 657,575 |
| 2017-12-04 | RGNX | Option Ex | 110 | 13.09 | 1,439 |
| 2017-12-04 | RGNX | Sale | 110 | 30.00 | 3,300 |
| 2017-11-27 | RGNX | Option Ex | 2,000 | 13.09 | 26,180 |
| 2017-11-27 | RGNX | Sale | 2,000 | 29.31 | 58,620 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-06-01 | HGSI | Option Ex | 22,904 | 12.56 | 287,674 |
| 2011-06-01 | HGSI | Sale | 22,904 | 27.11 | 620,950 |
| 2011-04-29 | HGSI | Option Ex | 28,015 | 11.08 | 310,406 |
| 2011-04-29 | HGSI | Sale | 28,015 | 28.98 | 812,014 |
| 2010-10-01 | HGSI | Option Ex | 22,903 | 12.56 | 287,661 |
| 2010-10-01 | HGSI | Sale | 22,903 | 29.80 | 682,394 |
| 2010-08-25 | HGSI | Option Ex | 18,461 | 9.78 | 180,548 |
| 2010-08-25 | HGSI | Sale | 18,461 | 28.00 | 516,908 |
| 2010-06-11 | HGSI | Sale | 18,461 | 26.07 | 481,204 |
| 2010-06-11 | HGSI | Option Ex | 18,461 | 9.78 | 180,548 |
| 2010-04-12 | HGSI | Option Ex | 30,000 | 10.89 | 326,700 |
| 2010-04-12 | HGSI | Sale | 30,000 | 32.76 | 982,709 |
| 2010-01-11 | HGSI | Sale | 1,216 | 30.76 | 37,401 |
| 2010-01-11 | HGSI | Option Ex | 35,000 | 10.89 | 381,150 |
| 2010-01-11 | HGSI | Sale | 33,784 | 30.71 | 1,037,472 |
| 2009-11-30 | HGSI | Option Ex | 36,923 | 9.78 | 361,106 |
| 2009-11-30 | HGSI | Sale | 36,923 | 27.37 | 1,010,582 |
| 2009-08-06 | HGSI | Option Ex | 81,534 | 6.96 | 567,884 |
| 2009-08-06 | HGSI | Sale | 88,955 | 14.58 | 1,296,874 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Simpson Curran (Chief Executive Officer of Regenxbio Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.